PRESS RELEASE published on 10/08/2025 at 07:00, 11 months 19 days ago Communiqué de presse : AlphaMedixTM (212Pb-DOTAMTATE) a satisfait l’ensemble des critères d’évaluation principaux d’efficacité lors de l’essai de phase 2, démontrant des bénéfices cliniquement significatifs chez les patients atteints AlphaMedixTM (212Pb-DOTAMTATE) satisfait les critères d'évaluation principaux d'efficacité dans l'essai de phase 2 pour les tumeurs neuroendocrines gastro-entéro-pancréatiques. Résultats prometteurs d'alphathérapie ciblée au plomb-212 Essai De Phase 2 Tumeurs Neuroendocrines AlphaMedixTM 212Pb-DOTAMTATE Alphathérapie Ciblée
BRIEF published on 09/24/2025 at 07:10, 1 year ago Sanofi investit 625 millions de dollars pour booster Sanofi Ventures Investissement Innovation Santé Numérique Sanofi Biotechnologies
BRIEF published on 09/24/2025 at 07:10, 1 year ago Sanofi invests $625 million to boost Sanofi Ventures Innovation Digital Health Investment Sanofi Biotechnologies
BRIEF published on 09/24/2025 at 07:05, 1 year ago Sanofi Releases Q3 2025 Aide Mémoire Investor Relations Sanofi Financial Modeling Results Announcement Q3 2025
PRESS RELEASE published on 09/24/2025 at 07:05, 1 year ago Communiqué de presse : Sanofi engage 625 millions de dollars supplémentaires dans Sanofi Ventures, afin d’accélérer ses investissements dans les biotechnologies et l’innovation en matière de santé numérique Sanofi investit 625 millions de dollars supplémentaires dans Sanofi Ventures pour accélérer les investissements en biotechnologies et innovation numérique dans la santé Investissement Innovation Santé Numérique Sanofi Biotechnologies
BRIEF published on 09/24/2025 at 07:05, 1 year ago Sanofi publie son aide-mémoire pour le troisième trimestre 2025 Relations Avec Les Investisseurs Sanofi Annonce Des Résultats Modélisation Financière T3 2025
PRESS RELEASE published on 09/24/2025 at 07:05, 1 year ago Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation Sanofi commits $625 million to Sanofi Ventures to boost biotech and digital health investments. Focus on immunology, rare diseases, neurology, vaccines Digital Health Investment Biotech Ventures Sanofi
PRESS RELEASE published on 09/24/2025 at 07:00, 1 year ago Press release: Availability of the Q3 2025 Aide mémoire Sanofi announces availability of Q3 2025 Aide mémoire for financial modeling purposes. Document covers non-comparable items, foreign currency impact, and share count Investors Sanofi Financial Modeling Aide Mémoire Q3 2025
BRIEF published on 09/23/2025 at 07:05, 1 year ago La thérapie SAR446268 de Sanofi progresse aux États-Unis Thérapie Génique Sanofi SAR446268 FDA Admission Dystrophie Myotonique
BRIEF published on 09/23/2025 at 07:05, 1 year ago Sanofi's SAR446268 Therapy Advances in the United States Gene Therapy Sanofi SAR446268 FDA Admission Myotonic Dystrophy
Published on 09/26/2026 at 01:00, 1 day 6 hours ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 1 day 8 hours ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 1 day 13 hours ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 1 day 16 hours ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/26/2026 at 15:30, 15 hours 39 minutes ago QUORRA X5 fait ses débuts mondiaux à REHACARE International 2026 en Allemagne
Published on 09/26/2026 at 15:30, 15 hours 39 minutes ago QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany
Published on 09/26/2026 at 15:15, 15 hours 54 minutes ago Timur Turlov Elected FIDE President, Becomes First Kazakh to Lead World Chess
Published on 09/26/2026 at 07:45, 23 hours 24 minutes ago Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/26/2026 at 00:01, 1 day 7 hours ago Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia
Published on 09/25/2026 at 17:45, 1 day 13 hours ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 1 day 13 hours ago Availability of the 2026 half-year financial report